M. Sideris and S. Papagrigoriadis, Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer, Anticancer Res, vol.34, pp.2061-2068, 2014.

E. Fearon and B. Vogelstein, A genetic model for colorectal tumorigenesis, Cell, vol.61, pp.759-767, 1990.

M. S. Pino and D. C. Chung, The chromosomal instability pathway in colon cancer, Gastroenterology, vol.138, pp.2059-2072, 2010.

M. T. Gyparaki, E. K. Basdra, and A. G. Papavassiliou, DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer, J. Mol. Med, vol.91, pp.1249-1256, 2013.

M. F. Müller, A. E. Ibrahim, and M. J. Arends, Molecular pathological classification of colorectal cancer, Virchows Arch, vol.469, pp.125-134, 2016.

D. Church, R. Midgley, and D. Kerr, Biomarkers in early-stage colorectal cancer: Ready for prime time?, Dig. Dis, vol.30, pp.27-33, 2012.

W. Palm and T. De-lange, How shelterin protects mammalian telomeres, Annu. Rev. Genet, vol.42, pp.301-334, 2008.

T. De-lange, How telomeres solve the end-protection problem, Science, vol.326, pp.948-952, 2009.

M. Armanios and E. H. Blackburn, The telomere syndromes, Nat. Rev. Genet, vol.13, pp.693-704, 2012.

, Int. J. Mol. Sci, vol.18, pp.1871-1886, 2017.

S. Feuerhahn, L. Chen, B. Luke, and A. Porro, No DDRama at chromosome ends: TRF2 takes centre stage, Trends Biochem. Sci, vol.40, pp.275-285, 2015.

C. A. Armstrong and K. Tomita, Fundamental mechanisms of telomerase action in yeasts and mammals: Understanding telomeres and telomerase in cancer cells, Open Biol, 2017.

J. Ye, V. M. Renault, K. Jamet, and E. Gilson, Transcriptional outcome of telomere signalling, Nat. Rev. Genet, vol.15, pp.491-503, 2014.

S. E. Artandi and R. A. Depinho, Telomeres and telomerase in cancer, Carcinogenesis, vol.31, pp.9-18, 2010.

J. Nandakumar and T. R. Cech, Finding the end: Recruitment of telomerase to telomeres, Nat. Rev. Mol. Cell. Biol, vol.14, pp.69-82, 2013.

S. T. Durant, Telomerase-independent paths to immortality in predictable cancer sub-types, J. Cancer, vol.3, pp.67-82, 2012.

H. A. Pickett and R. R. Reddel, Molecular mechanisms of activity and derepression of alternative lengthening of telomeres, Nat. Struct. Mol. Biol, vol.22, pp.875-880, 2015.

N. D. Hastie, M. Dempster, M. G. Dunlop, A. M. Thompson, D. K. Green et al., Telomere reduction in human colorectal carcinoma and with ageing, Nature, vol.346, pp.866-868, 1990.

M. Engelhardt, P. Drullinsky, J. Guillem, and M. A. Moore, Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer, Clin. Cancer Res, vol.3, 1931.

R. Gertler, R. Rosenberg, D. Stricker, J. Friederichs, A. Hoos et al., Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma, J. Clin. Oncol, vol.22, pp.1807-1814, 2004.

D. Broccoli, L. A. Godley, L. A. Donehower, H. E. Varmus, and T. De-lange, Telomerase activation in mouse mammary tumours: Lack of telomere shortening and evidence for regulation of telomerase with RNA cell proliferation, Mol. Cell. Biol, vol.16, pp.3765-3772, 1996.

G. Aubert, M. Hills, and P. M. Lansdorp, Telomere length measurement-Caveats and a critical assessment of the available technologies and tools, Mut. Res, vol.730, pp.59-67, 2012.

T. C. Chuang, S. Moshir, Y. Garini, A. Y. Chuang, I. T. Young et al., The three-dimensional organization of telomeres in the nucleus of mammalian cells, BMC Biol, vol.2, p.12, 2004.

B. J. Vermolen, Y. Garini, S. Mai, V. Mougey, T. Fest et al., Characterizing the three-dimensional organization of telomeres, Cytom. Part A, vol.67, pp.144-150, 2005.

M. Gadji, R. Vallente, L. Klewes, C. Righolt, L. Wark et al., Nuclear remodeling as a mechanism for genomic instability in cancer, Adv. Cancer Res, vol.112, pp.77-126, 2011.

S. Katayama, G. Shiota, M. Oshimura, and H. Kawasaki, Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer, J. Cancer Res. Clin. Oncol, vol.125, pp.405-410, 1999.

S. Takagi, Y. Kinouchi, N. Hiwatashi, M. Chida, F. Nagashima et al., Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas, Cancer, vol.86, pp.1431-1436, 1999.

K. Nakamura, E. Furugori, Y. Esaki, T. Arai, M. Sawabe et al., Correlation of telomere lengths in normal and cancers tissue in the large bowel, Cancer Lett, vol.158, pp.179-184, 2000.

R. R. Plentz, S. U. Wiemann, P. Flemming, P. N. Meier, S. Kubicka et al., Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer, Gut, vol.52, pp.1304-1307, 2003.

C. Garcia-aranda, C. De-juan, A. Diaz-lopez, A. Sanchez-pernaute, A. Torres et al., Correlations of telomere length, telomerase activity and telomeric-repeat binding factor 1 expression in colorectal carcinoma, Cancer, vol.106, pp.541-551, 2006.

J. O'sullivan, R. A. Risques, M. T. Mandelson, L. Chen, T. A. Brentnall et al., Telomere length in the colon declines with age: A relation to colorectal cancer?, Cancer Epidemiol. Biomark. Prev, vol.15, pp.573-577, 2006.

, Int. J. Mol. Sci, vol.18, p.1871, 2017.

C. M. Raynaud, S. J. Jang, P. Nuciforo, S. Lantuejoul, E. Brambilla et al., Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions, Ann. Oncol, vol.19, pp.1875-1881, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00360905

E. Rampazzo, R. Bertorelle, L. Serra, L. Terrin, C. Candiotto et al., Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers, Br. J. Cancer, vol.102, pp.1300-1305, 2010.

C. Valls, C. Piñol, J. M. Reñé, J. Buenestado, and J. Viñas, Telomere length is a prognostic factor for overall survival in colorectal cancer, Colorectal Dis, vol.13, pp.1265-1272, 2011.

L. Roger, R. E. Jones, N. H. Heppel, G. T. Williams, J. R. Sampson et al., Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability, J. Natl. Cancer Inst, vol.105, pp.1202-1211, 2013.

R. Bertorelle, E. Rampazzo, S. Pucciarelli, D. Nitti, and . De-rossi, A. Telomeres, telomerase and colorectal cancer. World J. Gastroenterol, vol.20, 1940.

S. Takagi, Y. Kinouchi, N. Hiwatashi, F. Nagashima, M. Chida et al., Relationship between microsatellite instability and telomere shortening in colorectal cancer, Dis. Colon Rectum, vol.43, pp.12-17, 2000.

H. R. Kim, Y. J. Kim, H. J. Kim, S. K. Kim, and J. H. Lee, Telomere length changes in colorectal cancers and polyps, J. Korean Med. Sci, vol.17, pp.360-365, 2002.

C. Piñol-felis, T. Fernández-marcelo, J. Viñas-salas, and C. Valls-bautista, Telomeres and telomerase in the clinical management of colorectal cancer, Clin. Transl. Oncol, vol.19, pp.399-408, 2017.

B. Nera, H. Huang, T. Lai, and L. Xu, Elevated levels of TRF2 induce telomeric ultrafine anaphase bridges and rapid telomere deletions, Nat. Commun, 2015.

H. Knecht, N. A. Johnson, T. Haliotis, D. Lichtensztejn, and S. Mai, Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells, Lab. Investig, vol.97, pp.772-781, 2017.

Y. Maida, S. Kyo, T. Kanaya, Z. Wang, N. Yatabe et al., Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway, Oncogene, vol.21, pp.4071-4079, 2002.

S. Heeg, N. Hirt, A. Queisser, H. Schmieg, M. Thaler et al., EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-? in a cellular model of oral-esophageal carcinogenesis, Cancer Sci, vol.102, pp.351-360, 2011.

A. Lièvre, J. B. Bachet, D. Le-corre, V. Boige, B. Landi et al., KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer, Cancer Res, vol.66, pp.3992-3995, 2006.

T. A. Augustine, M. Baig, A. Sood, T. Budagov, G. Atzmon et al., Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer, Br. J. Cancer, vol.112, pp.313-318, 2015.

L. Xu and E. H. Blackburn, Human cancer cells harbor t-stumps, a distinct class of extremely short telomeres, Mol. Cell, vol.28, pp.315-327, 2007.

M. Gadji, D. Fortin, A. M. Tsanaclis, Y. Garini, N. Katzir et al., Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients, Neoplasia, vol.12, pp.183-191, 2010.

H. Knecht, N. Kongruttanachok, B. Sawan, J. Brossard, S. Prévost et al., Three-dimensional telomere signatures of Hodgkin-and Reed-Sternberg cells at diagnosis identify Patients with poor response to conventional chemotherapy, Transl. Oncol, vol.5, pp.269-277, 2012.

C. D. Putnam, A. Srivatsan, R. Nene, S. L. Martinez, S. P. Clotfelter et al., A genetic network that suppresses genome rearrangements in Saccharomyces cerevisiae and contains defects in cancers, Nat. Commun, 2016.

S. B. Edge and C. C. Compton, The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM, Ann. Surg. Oncol, vol.17, pp.1471-1474, 2010.

A. Umar, C. R. Boland, J. P. Terdiman, S. Syngal, A. De-la-chapelle et al., Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability, J. Natl. Cancer Inst, vol.96, pp.261-268, 2004.

K. Truninger, M. Menigatti, J. Luz, A. Russell, R. Haider et al., Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer, Gastroenterology, vol.128, pp.1160-1171, 2005.

A. Fogli, M. V. Demattei, L. Corset, C. Vaurs-barrière, E. Chautard et al., Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis, J. Neurooncol, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02402201